1
Richard Schwartz, John Michael Berry, Weidong Cui: Methods of producing influenza vaccine compositions. MedImmune Vaccines, August 28, 2007: US07262045 (19 worldwide citation)

Methods and compositions for the optimization of production of influenza viruses suitable as influenza vaccines are provided.


2
Richard Schwartz, John Michael Berry, Ajit Subramanian, Xiao Shi: Non-tumorigenic MDCK cell line for propagating viruses. Medimmune, March 2, 2010: US07670837 (5 worldwide citation)

The present invention provides novel MDCK-derived adherent non-tumorigenic cell lines that can be grown in the presence or absence of serum. The cell lines of the present invention are useful for the production of vaccine material (e.g., viruses). More specifically, the cell lines of the present inv ...


3
Richard Schwartz, John Michael Berry, Ajit Subramanian, Xiao Shi: Non-tumorigenic MDCK cell line for propagating viruses. Medimmune, Grant Anderson, February 21, 2012: US08119388 (2 worldwide citation)

The present invention provides novel MDCK-derived adherent non-tumorigenic cell lines that can be grown in the presence or absence of serum. The cell lines of the present invention are useful for the production of vaccine material (e.g., viruses). More specifically, the cell lines of the present inv ...


4
Richard Schwartz, John Michael Berry, Ajit Subramanian, Xiao Shi: Non-tumorigenic MDCK cell line for propagating viruses. Medimmune Vaccines, Johnathan Klein Evans, August 24, 2006: US20060188977-A1

The present invention provides novel MDCK-derived adherent non-tumorigenic cell lines that can be grown in the presence or absence of serum. The cell lines of the present invention are useful for the production of vaccine material (e.g., viruses). More specifically, the cell lines of the present inv ...


5
Richard SCHWARTZ, John Michael Berry, Ajit SUBRAMANIAN, Xiao SHI: Non-tumorigenic mdck cell line for propagating viruses. Medimmune, Medimmune, Patrick Scott Alban, May 6, 2010: US20100112000-A1

The present invention provides novel MDCK-derived adherent non-tumorigenic cell lines that can be grown in the presence or absence of serum. The cell lines of the present invention are useful for the production of vaccine material (e.g., viruses). More specifically, the cell lines of the present inv ...


6
Richard Schwartz, John Michael Berry, Ajit Subramanian, Xiao Shi: Non-tumorigenic mdck cell line for propagating viruses. Medlmmune Way, May 10, 2012: US20120115206-A1

The present invention provides novel MDCK-derived adherent non-tumorigenic cell lines that can be grown in the presence or absence of serum. The cell lines of the present invention are useful for the production of vaccine material (e.g., viruses). More specifically, the cell lines of the present inv ...



Click the thumbnails below to visualize the patent trend.